Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1962 1
1963 1
1965 1
1966 1
1967 1
1968 1
1969 1
1972 1
1973 4
1974 2
1975 1
1977 2
1978 1
1980 1
1981 3
1982 5
1983 2
1984 5
1985 8
1986 4
1987 5
1988 1
1989 9
1990 8
1991 5
1992 6
1993 5
1994 5
1995 11
1996 7
1997 7
1998 8
1999 6
2000 9
2001 6
2002 9
2003 5
2004 11
2005 4
2006 9
2007 16
2008 14
2009 13
2010 29
2011 35
2012 29
2013 21
2014 26
2015 26
2016 28
2017 27
2018 26
2019 30
2020 17
2021 25
2022 24
2023 23
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

580 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A, Rodriguez-Ruiz JP, Malhotra-Kumar S, Powell C, Faust SN, Alcock AE, Hall D, Robinson G, Hawcutt DB, Lyttle MD, Gibb DM, Sharland M; PERUKI, GAPRUKI, and the CAP-IT Trial Group. Bielicki JA, et al. Among authors: gibb dm. JAMA. 2021 Nov 2;326(17):1713-1724. doi: 10.1001/jama.2021.17843. JAMA. 2021. PMID: 34726708 Free PMC article. Clinical Trial.
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
Turkova A, Wills GH, Wobudeya E, Chabala C, Palmer M, Kinikar A, Hissar S, Choo L, Musoke P, Mulenga V, Mave V, Joseph B, LeBeau K, Thomason MJ, Mboizi RB, Kapasa M, van der Zalm MM, Raichur P, Bhavani PK, McIlleron H, Demers AM, Aarnoutse R, Love-Koh J, Seddon JA, Welch SB, Graham SM, Hesseling AC, Gibb DM, Crook AM; SHINE Trial Team. Turkova A, et al. Among authors: gibb dm. N Engl J Med. 2022 Mar 10;386(10):911-922. doi: 10.1056/NEJMoa2104535. N Engl J Med. 2022. PMID: 35263517 Free PMC article. Clinical Trial.
Mortality after fluid bolus in African children with severe infection.
Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM; FEAST Trial Group. Maitland K, et al. Among authors: gibb dm. N Engl J Med. 2011 Jun 30;364(26):2483-95. doi: 10.1056/NEJMoa1101549. Epub 2011 May 26. N Engl J Med. 2011. PMID: 21615299 Free article. Clinical Trial.
Ebola vaccination.
Fitzgerald F, Yeung S, Gibb DM, Baion DE, Pollard A. Fitzgerald F, et al. Among authors: gibb dm. Lancet. 2015 Dec 19;386(10012):2478. doi: 10.1016/S0140-6736(15)01243-X. Epub 2015 Dec 18. Lancet. 2015. PMID: 26738714 No abstract available.
Sickle cell inflammation: is HbS the answer?
Gibb DR, Hudson KE. Gibb DR, et al. Blood. 2022 Nov 3;140(18):1921-1923. doi: 10.1182/blood.2022018078. Blood. 2022. PMID: 36326792 Free article. No abstract available.
Investigating anti-D in an individual with the weak D type 2 genotype.
Phou S, Nguyen N, Revilla J, Rodberg K, Gibb DR, Pepkowitz SH, Klapper EB. Phou S, et al. Among authors: gibb dr. Immunohematology. 2022 Sep 22;38(3):77-81. doi: 10.21307/immunohematology-2022-046. Print 2022 Sep 1. Immunohematology. 2022. PMID: 36190200
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
Barratt S, Bielicki JA, Dunn D, Faust SN, Finn A, Harper L, Jackson P, Lyttle MD, Powell CV, Rogers L, Roland D, Stöhr W, Sturgeon K, Vitale E, Wan M, Gibb DM, Sharland M. Barratt S, et al. Among authors: gibb dm. Health Technol Assess. 2021 Nov;25(60):1-72. doi: 10.3310/hta25600. Health Technol Assess. 2021. PMID: 34738518 Free article. Clinical Trial.
Tuberculous meningitis: new tools and new approaches required.
Seddon JA, Thwaites GE; Tuberculous Meningitis International Research Consortium. Seddon JA, et al. Wellcome Open Res. 2019 Nov 19;4:181. doi: 10.12688/wellcomeopenres.15591.1. eCollection 2019. Wellcome Open Res. 2019. PMID: 31803849 Free PMC article.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Gafar F, Wasmann RE, McIlleron HM, Aarnoutse RE, Schaaf HS, Marais BJ, Agarwal D, Antwi S, Bang ND, Bekker A, Bell DJ, Chabala C, Choo L, Davies GR, Day JN, Dayal R, Denti P, Donald PR, Engidawork E, Garcia-Prats AJ, Gibb D, Graham SM, Hesseling AC, Heysell SK, Idris MI, Kabra SK, Kinikar A, Kumar AKH, Kwara A, Lodha R, Magis-Escurra C, Martinez N, Mathew BS, Mave V, Mduma E, Mlotha-Mitole R, Mpagama SG, Mukherjee A, Nataprawira HM, Peloquin CA, Pouplin T, Ramachandran G, Ranjalkar J, Roy V, Ruslami R, Shah I, Singh Y, Sturkenboom MGG, Svensson EM, Swaminathan S, Thatte U, Thee S, Thomas TA, Tikiso T, Touw DJ, Turkova A, Velpandian T, Verhagen LM, Winckler JL, Yang H, Yunivita V, Taxis K, Stevens J, Alffenaar JC; Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs. Gafar F, et al. Among authors: gibb d. Eur Respir J. 2023 Mar 9;61(3):2201596. doi: 10.1183/13993003.01596-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36328357 Free PMC article. Review.
580 results